Literature DB >> 7449762

Correlation of enzymatic activity and anticoagulant properties of phospholipase A2.

H M Verheij, M C Boffa, C Rothen, M C Bryckaert, R Verger, G H de Haas.   

Abstract

Some highly purified phospholipases A from the venom of viperidae, crotalidae and elapidae were found to hve anticoagulant properties. All phospholipases which exhibited anticoagulant properties are characterized by a high isoelectric point, but not all strongly basic phospholipases are anticoagulant. Anticoagulant phospholipases hydrolyse highly packed monomolecular films of phospholipids without any lag time while non-anticoagulant phospholipases present considerable induction times indicative of a low penetrating power. When the ester linkages in the procoagulant lipids were replaced by the non-hydrolysable ether bonds, the mixture retained its clotting ability even in the presence of phospholipases, thus suggesting that anticoagulant phospholipases prevent clot formation by hydrolysis of phospholipids. This was confirmed by chemical modification of phospholipases, viz. alkylation of the active-centre histidine with 1-bromo-octan-2-one. This modification yielded proteins which had lost their anticoagulant properties but which retained a high affinity for phospholipids.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7449762     DOI: 10.1111/j.1432-1033.1980.tb04982.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  20 in total

1.  Unusually high conservation of untranslated sequences in cDNAs for Trimeresurus flavoviridis phospholipase A2 isozymes.

Authors:  T Ogawa; N Oda; K Nakashima; H Sasaki; M Hattori; Y Sakaki; H Kihara; M Ohno
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 2.  Anticoagulant proteins from snake venoms: structure, function and mechanism.

Authors:  R Manjunatha Kini
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

3.  Phospholipase A2 activity of low density lipoprotein: evidence for an intrinsic phospholipase A2 activity of apoprotein B-100.

Authors:  S Parthasarathy; J Barnett
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein.

Authors:  S Parthasarathy; U P Steinbrecher; J Barnett; J L Witztum; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.

Authors:  L Arbibe; K Koumanov; D Vial; C Rougeot; G Faure; N Havet; S Longacre; B B Vargaftig; G Béréziat; D R Voelker; C Wolf; L Touqui
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

6.  Crystallization and preliminary X-ray crystallographic analysis of the heterodimeric crotoxin complex and the isolated subunits crotapotin and phospholipase A2.

Authors:  K F Santos; M T Murakami; A C O Cintra; M H Toyama; S Marangoni; V P Forrer; J R Brandão Neto; I Polikarpov; R K Arni
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-03-12

Review 7.  Engineered nanoparticles mimicking cell membranes for toxin neutralization.

Authors:  Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Liangfang Zhang
Journal:  Adv Drug Deliv Rev       Date:  2015-04-11       Impact factor: 15.470

8.  Phospholipase A2 as a mechanosensor.

Authors:  J Y Lehtonen; P K Kinnunen
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

9.  Properties of receptors for neurotoxic phospholipases A2 in different tissues.

Authors:  G Lambeau; M Lazdunski; J Barhanin
Journal:  Neurochem Res       Date:  1991-06       Impact factor: 3.996

10.  Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid.

Authors:  B S Vishwanath; A A Fawzy; R C Franson
Journal:  Inflammation       Date:  1988-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.